61/318US=22 / Urologia
Mizutani Y, kawauchi A, Bonavida B, Miki T. Smac/DIABLO: a proapoptotic molecular target in renal cell cancer. In: Bukowski RM, Figlin RA, Motzer RJ. Renal cell carcinoma: molecular targets and clinical applications. 2ªed. New York: Humana Press, 2009. p. 335-46. ISBN 978-1-58829-737-2.

CARCINOMA DE CELULAS RENAIS; SMAC / DIABLO; PROGNOSTICO; APOPTOSE; CISPLATINA; XIAP; RCC; TRAIL

62/318US=24 / Patologia
Rosen PP. Invasive duct carcinoma: assessment of prognosis, morphologic prognostic markers, and tumor growth rate. In: ___. Rosen's breast pathology. 3rd ed. Philadelphia: Lippincott Willians & Wilkins, 2009. p. 358-404. ISBN 978-0-7817-7137-5.

MAMA; CARCINOMA INVASIVO; NECROSE; APOPTOSE; TELOMERASE; EMBOLOS TUMORAIS LINFATICOS; INVASAO NEOPLASICA EM VASOS SANGUINEOS; ANGIOGENESE; INVASAO PERINEURAL; TAXA DE CRESCIMENTO DO TUMOR; MORFOMETRIA NUCLEAR; FENOTIPO BASAL

63/318US=8 / Laboratório
Hockenbery DM, Korsmeyer SJ. Cell death. In: Hoffman R, Benz EJ Jr, Shattil SJ, Furie B, Silberstein LE, McGlave P, Heslop HE. Hematology: basic principles and practice. 5th ed. Philadelphia: Churchill Livingstone, 2009. p. 72-80. ISBN 978-0-443-06715-0.

MORTE CELULAR; TURNOVER CELULAR; RENOVACAO CELULAR EPIDERMICA; RESPOSTA AO DANO CELULAR; APOPTOSE; CASPASES; ATIVACAO DE PRO-CASPASES; APOPTOSSOMAS; BCL-2; BH3; VIAS DE APOPTOSE; DANOS AO DNA; RESPOSTA A PROTEINAS DESDOBRADAS (UPR); ONCOGENE; SINALIZADORAS DE SOBREVIVENCIA

64/318US=8 / Laboratório
Gerson SL, Bhalla KN, Grant S, Natarajan K, Creger RJ, DeRemer D. Pharmacology and molecular mechanisms of antineoplastic agents for hematologic malignancies. In: Hoffman R, Benz EJ Jr, Shattil SJ, Furie B, Silberstein LE, McGlave P, Heslop HE. Hematology: basic principles and practice. 5th ed. Philadelphia: Churchill Livingstone, 2009. p. 839-98. ISBN 978-0-443-06715-0.

FARMACOLOGIA; MECANISMOS MOLECULARES; AGENTES ANTINEOPLASICOS; DOENCAS HEMATOLOGICAS; CINETICA CELULAR; CICLO CELULAR; CRESCIMENTO DO TUMOR; AGENTES QUIMIOTERAPEUTICOS; APOPTOSE; RESISTENCIA A DROGAS; AGENTES ALQUILANTES; AGENTES ANTIMICROTUBULOS; ANTIMETABOLITOS; INIBIDORES DA TOPOISOMERASE; ANALOGOS DE PLATINA

65/318US=8 / Laboratório
DeAngelo DJ, Stone RM. Myelodysplastic syndromes: biology and treatment. In: Hoffman R, Benz EJ Jr, Shattil SJ, Furie B, Silberstein LE, McGlave P, Heslop HE. Hematology: basic principles and practice. 5th ed. Philadelphia: Churchill Livingstone, 2009. p. 1051-72. ISBN 978-0-443-06715-0.

SINDROMES MIELODISPLASICAS; MIELODISPLASIA; APOPTOSE; HEMATOPOIESE; MIELODISPLASIA. DIAGNOSTICO; MIELODISPLASIA. CLASSIFICACAO; MIELODISPLASIA. PROGNOSTICO; SINDROME 5Q; MIELODISPLASIA HIPOCELULAR; MIELOFIBROSE; TROMBOCITOSE; MIELODISPLASIA. TRATAMENTO

66/318US=39 / Patologia
Lemasters JJ. Molecular mechanisms of cell death. In: Coleman WB, Tsongalis GJ. Molecular pathology: the molecular basis of human disease. Amsterdam: Elsevier, 2009. p. 3-24. ISBN 978-0-12-374419-7.

MORTE CELULAR; MECANISMOS MOLECULARES; NECROSE; APOPTOSE; NECROSE ONCOTICA; DISFUNCAO MITOCONDRIAL; DESACOPLAMENTO MITOCONDRIAL; TRANSICAO DE PERMEABILIDADE MITOCONDRIAL; MITOCONDRIA; NUCLEO; RETICULO ENDOPLASMATICO; LISOSSOMOS

67/318US=45 / Biol/Mol
Apte SP, Sarangarajan R. Metabolic modulation of carcinogenesis. In: Apte SP, Sarangarajan R, editors. Cellular respiration and carcinogenesis. New Jersey: Humana Press, 2009. p. 103-18. ISBN 978-1-934115-07-7.

MODULACAO METABOLICA DA CARCINOGENESE; GLICOLISE; FOSFORILACAO OXIDATIVA; APOPTOSE; CARCINOGENESE; CICLO CELULAR; HIPOXIA; WARBURG; RESTRICAO CALORICA; CITOCROMO C

68/318US=45 / Biol/Mol
Werner E. How cancer cells escape death. In: Apte SP, Sarangarajan R, editors. Cellular respiration and carcinogenesis. New Jersey: Humana Press, 2009. p. 161-78. ISBN 978-1-934115-07-7.

BCL-2; CELULAS CANCEROSAS ESCAPAR DA MORTE; APOPTOSE; MITOCONDRIAS; PRO-SURVIVAL; AMBIENTE; GLICOLISE

69/318US=60 / Biol/Mol
Karna P, Yang L. Apoptotic signaling pathway and resistance to apoptosis in breast cancer stem cells. In: Chen GG, Lai PBS. Apoptosis in carcinogenesis and chemotherapy: apoptosis in cancer. New York: Springer, 2009. p. 1-23. ISBN 978-1-4020-9596-2.

RESISTENCIA A APOPTOSE; CELULAS TRONCO EM NEOPLASIAS DE MAMA; TERAPIA DE ALVO MOLECULAR; VIA APOPTOTICA; MECANISMOS DE RESISTENCIA A APOPTOSE

70/318US=60 / Biol/Mol
Karam JA, Hsieh JT. Anti-cancer strategy of transitional cell carcinoma of bladder based on induction of different types of programmed cell deaths. In: Chen GG, Lai PBS. Apoptosis in carcinogenesis and chemotherapy: apoptosis in cancer. New York: Springer, 2009. p. 25-50. ISBN 978-1-4020-9596-2.

APOPTOSE; AUTOFAGIA; CANCER DE BEXIGA; NECROSE; MORTE CELULAR PROGRAMADA; VIAS DE SINALIZACAO

71/318US=60 / Biol/Mol
Hietanen S. Apoptosis in carcinogenesis and chemotherapy of the uterine cervix. In: Chen GG, Lai PBS. Apoptosis in carcinogenesis and chemotherapy: apoptosis in cancer. New York: Springer, 2009. p. 51-73. ISBN 978-1-4020-9596-2.

APOPTOSE; MORTE CELULAR PROGRAMADA; QUIMIOTERAPIA; CARCINOGENESE DO COLO UTERINO; PAPILOMAVIRUS HUMANO (HPV)

72/318US=60 / Biol/Mol
Yang SY, Sales KM, Winslet MC. Apoptosis in colorectal tumorigenesis and chemotherapy. In: Chen GG, Lai PBS. Apoptosis in carcinogenesis and chemotherapy: apoptosis in cancer. New York: Springer, 2009. p. 75-109. ISBN 978-1-4020-9596-2.

APOPTOSE; MORTE CELULAR PROGRAMADA; QUIMIOTERAPIA; CARCINOGENESE DO COLO UTERINO; CANCER COLORRETAL; PAPILOMAVIRUS HUMANO (HPV); CARCINOMA COLORRETAL. EPIDEMIOLOGIA; CARCINOMA COLORRETAL. ETIOLOGIA; CARCINOMA COLORRETAL. PATOLOGIA; CARCINOMA COLORRETAL. TRATAMENTO; TUMORIGENESE COLORRETAL; ADENOMA; MUTACAO GENICA

73/318US=60 / Biol/Mol
Nicholl MB, Hoon DSB. Apoptosis in cutaneous melanoma. In: Chen GG, Lai PBS. Apoptosis in carcinogenesis and chemotherapy: apoptosis in cancer. New York: Springer, 2009. p. 111-25. ISBN 978-1-4020-9596-2.

APOPTOSE; MORTE CELULAR PROGRAMADA; MELANOMA CUTANEO; APAF-1; SURVIVINA; INIBIDORES DE APOPTOSE

74/318US=60 / Biol/Mol
Li Y, Martin RCG. Apoptosis in carcinogenesis and chemotherapy - esophageal cancer. In: Chen GG, Lai PBS. Apoptosis in carcinogenesis and chemotherapy: apoptosis in cancer. New York: Springer, 2009. p. 127-56. ISBN 978-1-4020-9596-2.

APOPTOSE; MORTE CELULAR PROGRAMADA; CARCINOGENESE; QUIMIOTERAPIA; CANCER DE ESOFAGO; VIAS DE SINALIZACAO; CARCINOMA ESOFAGICO; ADENOCARCINOMA ESOFAGICO

75/318US=60 / Biol/Mol
Balcer-Kubiczek EK, Garofalo MC. Molecular targets in gastric cancer and apoptosis. In: Chen GG, Lai PBS. Apoptosis in carcinogenesis and chemotherapy: apoptosis in cancer. New York: Springer, 2009. p. 157-92. ISBN 978-1-4020-9596-2.

APOPTOSE; MORTE CELULAR PROGRAMADA; ALVOS MOLECULARES; CANCER GASTRICO; REGULADORES DO CANCER; MICRORNA; CELULAS-TRONCO; CANCER GASTRICO. EPIDEMIOLOGIA; CANCER GASTRICO. CLASSIFICACAO PATOLOGICA; CANCER GASTRICO. TRATAMENTO; CANCER GASTRICO. ASPECTOS MOLECULARES; VIAS APOPTOTICAS

76/318US=60 / Biol/Mol
Yarde DN, Tao J. Apoptosis and the tumor microenvironment in hematologic malignancies. In: Chen GG, Lai PBS. Apoptosis in carcinogenesis and chemotherapy: apoptosis in cancer. New York: Springer, 2009. p. 193-218. ISBN 978-1-4020-9596-2.

APOPTOSE; MORTE CELULAR PROGRAMADA; RESISTENCIA A DROGA; LEUCEMIA; LINFOMA; MIELOMA MULTIPLO; MICROAMBIENTE DO TUMOR

77/318US=60 / Biol/Mol
Ma S, Chen GG, Lai PBS. Bcl-2 family members in hepatocellular carcinoma (HCC) - mechanisms and therapeutic potentials. In: Chen GG, Lai PBS. Apoptosis in carcinogenesis and chemotherapy: apoptosis in cancer. New York: Springer, 2009. p. 219-35. ISBN 978-1-4020-9596-2.

APOPTOSE; MORTE CELULAR PROGRAMADA; FAMILIA BCL-2; DOMINIOS BH3; CARCINOMA HEPATOCELULAR; CANCER DE FIGADO; CANCER HEPATICO; HEPATOCARCINOGENESE

78/318US=60 / Biol/Mol
Redondo M, Fúnez R, Esteban F. Apoptosis in the development and treatment of laryngeal cancer: role of p53, Bcl-2 and clusterin. In: Chen GG, Lai PBS. Apoptosis in carcinogenesis and chemotherapy: apoptosis in cancer. New York: Springer, 2009. p. 237-49. ISBN 978-1-4020-9596-2.

APOPTOSE; MORTE CELULAR PROGRAMADA; CANCER DE LARINGE; P53; BCL-2; CLUSTERINA

79/318US=60 / Biol/Mol
Leung KC, Chen GG. Cyclooxygenase 2 and its metabolites: implications for lung cancer therapy. In: Chen GG, Lai PBS. Apoptosis in carcinogenesis and chemotherapy: apoptosis in cancer. New York: Springer, 2009. p. 251-72. ISBN 978-1-4020-9596-2.

APOPTOSE; MORTE CELULAR PROGRAMADA; CANCER DE PULMAO; CICLOOXIGENASE 2; PROSTAGLANDINA; COX-2; QUIMIOTERAPIA

80/318US=60 / Biol/Mol
Lee MH, Yang H, Zhao R, Yeung SCJ. Roles of negative and positive growth regulators in nasopharyngeal carcinoma. In: Chen GG, Lai PBS. Apoptosis in carcinogenesis and chemotherapy: apoptosis in cancer. New York: Springer, 2009. p. 273-94. ISBN 978-1-4020-9596-2.

APOPTOSE; MORTE CELULAR PROGRAMADA; CANCER NASOFARINGEO; REGULADORES DE CRESCIMENTO; CICLO CECLULAR; CARCINOMA NASOFARINGEO; SINALIZACAO DE TRANSDUCAO; REGULADORES DE CRESCIMENTO NEGATIVO; REGULADORES DE CRESCIMENTO POSITIVO

Primeira | Anterior | Próxima | Última